Gossamer Bio, Inc. (GOSS)
10.70
+0.92
(+9.47%)
USD |
NASDAQ |
Oct 28, 16:00
10.42
-0.28
(-2.57%)
After-Hours: 20:00
Gossamer Bio Total Return Price : 10.70 for Oct. 28, 2026
Total Return Price Chart
Historical Total Return Price Data
| Date | Value |
|---|---|
| October 27, 2026 | 9.77 |
| October 26, 2026 | 9.15 |
| October 23, 2026 | 9.605 |
| October 22, 2026 | 9.46 |
| October 21, 2026 | 9.79 |
| October 20, 2026 | 9.58 |
| October 19, 2026 | 8.43 |
| October 16, 2026 | 8.77 |
| October 15, 2026 | 8.89 |
| October 14, 2026 | 8.905 |
| October 13, 2026 | 9.76 |
| October 12, 2026 | 9.28 |
| October 09, 2026 | 9.31 |
| October 08, 2026 | 9.88 |
| October 07, 2026 | 10.18 |
| October 06, 2026 | 10.78 |
| October 05, 2026 | 10.65 |
| October 02, 2026 | 10.71 |
| October 01, 2026 | 10.93 |
| September 30, 2026 | 11.85 |
| September 29, 2026 | 11.58 |
| September 28, 2026 | 11.52 |
| September 25, 2026 | 10.94 |
| September 24, 2026 | 10.93 |
| September 23, 2026 | 10.99 |
| Date | Value |
|---|---|
| September 22, 2026 | 11.69 |
| September 21, 2026 | 11.28 |
| September 18, 2026 | 10.73 |
| September 17, 2026 | 11.94 |
| September 16, 2026 | 10.96 |
| September 15, 2026 | 10.38 |
| September 14, 2026 | 10.70 |
| September 11, 2026 | 10.73 |
| September 10, 2026 | 11.39 |
| September 09, 2026 | 12.78 |
| September 08, 2026 | 14.39 |
| September 04, 2026 | 14.02 |
| September 03, 2026 | 14.05 |
| September 02, 2026 | 13.82 |
| September 01, 2026 | 13.39 |
| August 31, 2026 | 13.60 |
| August 28, 2026 | 13.61 |
| August 27, 2026 | 13.61 |
| August 26, 2026 | 13.91 |
| August 25, 2026 | 16.36 |
| August 24, 2026 | 14.00 |
| August 21, 2026 | 12.38 |
| August 20, 2026 | 12.60 |
| August 19, 2026 | 12.53 |
| August 18, 2026 | 11.45 |
Total Return Price Definition
The total return price allows investors to view the performance of a security inclusive of both price appreciation and dividends/distributions.
Total Return Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Return Price Benchmarks
| United Therapeutics Corp. | 586.35 |
| Arbutus Biopharma Corp. | 4.325 |
| Kura Oncology, Inc. | 10.73 |
| ACADIA Pharmaceuticals, Inc. | 20.30 |
| Alnylam Pharmaceuticals, Inc. | 232.44 |